NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 48 filers reported holding NUVALENT INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $37,350,625 | -44.6% | 812,500 | -49.2% | 0.58% | -36.3% |
Q2 2023 | $67,472,000 | +36.9% | 1,600,000 | -15.3% | 0.92% | +25.2% |
Q1 2023 | $49,281,088 | +6.4% | 1,888,888 | +21.4% | 0.73% | +5.6% |
Q4 2022 | $46,324,428 | +127.1% | 1,555,555 | +48.2% | 0.69% | +83.6% |
Q3 2022 | $20,402,000 | +43.4% | 1,049,471 | 0.0% | 0.38% | +34.2% |
Q2 2022 | $14,231,000 | -2.4% | 1,049,471 | 0.0% | 0.28% | +5.6% |
Q1 2022 | $14,577,000 | -20.9% | 1,049,471 | -4.8% | 0.27% | -15.3% |
Q4 2021 | $18,431,000 | -17.3% | 1,102,671 | -12.3% | 0.31% | -10.3% |
Q3 2021 | $22,288,000 | – | 1,257,671 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,341,024 | $436,140,000 | 8.51% |
Fairmount Funds Management LLC | 914,614 | $20,625,000 | 7.50% |
Bain Capital Life Sciences Investors, LLC | 3,428,014 | $77,302,000 | 4.80% |
VR Adviser, LLC | 803,951 | $18,129,000 | 2.33% |
Boxer Capital, LLC | 1,210,192 | $27,290,000 | 0.95% |
BVF INC/IL | 448,512 | $10,114,000 | 0.40% |
Avoro Capital Advisors LLC | 1,257,671 | $22,288,000 | 0.35% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,052,394 | $23,731,000 | 0.28% |
Perceptive Advisors | 750,000 | $16,913,000 | 0.25% |
Logos Global Management LP | 134,650 | $2,733,000 | 0.20% |